
Where Can You Find Expert Cancer Care Near You in Toms River and Ocean County, NJ?
Transportation is an underestimated burden of cancer care. When visiting the oncologist once or twice each week for chemotherapy, the travel time adds up. A
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
A colon cancer diagnosis is usually confirmed with a biopsy taken during an exam of the colon. This exam often follows abnormal colon cancer screening results or new signs and symptoms. From there, the next steps typically include more testing, staging, and treatment planning.
Regional Cancer Care Associates (RCCA) is a group of more than 90 medical oncologists and hematologists who treat patients who have solid tumors, blood-based cancers, and benign blood disorders at more than 20 locations near you throughout New Jersey, Connecticut, and Massachusetts. RCCA strives to educate patients while providing innovative care. Here, we discuss what patients just diagnosed with colon cancer can expect, from testing and staging to treatment planning.
Colon cancer forms in the tissues of the colon, the main part of the large intestine. To confirm a diagnosis, a doctor, typically a gastroenterologist, examines the colon, and a pathologist, a doctor who studies cells and tissue under a microscope, checks samples for cancer.
Tests used to evaluate the colon and confirm a colon cancer diagnosis may include:
A pathology report reviews key findings from such tests. Most colon cancers are adenocarcinomas, which start in mucus-making gland cells within the colon. Less common types of colon cancer include carcinoid tumors, a type of neuroendocrine tumor, and gastrointestinal stromal tumors.
The pathology report may also describe:
Additionally, biomarker tests look for changes in genes, proteins, and other substances in cancer cells. Results can help show if targeted therapy or immunotherapy is likely to help. Common biomarker tests include:
Staging is the process of finding out if cancer has spread within the colon or to other parts of the body. The resulting stage, one of several colon cancer stages, describes how much cancer is in the body and helps the care team plan treatment. When colorectal cancer is found before it spreads beyond where it started, the 5-year relative survival rate is 91.3%.
Clinical staging uses exams, biopsies, and imaging done before surgery. A pathologic stage comes from tissue removed during surgery and is likely to be more accurate, which means the final stage may be set after an operation. Staging relies on a set of tests and a standard system for describing results.
Staging tests may include:
Most colon cancers are staged with the tumor, node, metastasis (TNM) system. The T describes how far the tumor has grown into the colon wall, the N describes spread to nearby lymph nodes, and the M describes spread to distant sites.
Each stage of colon cancer is defined as follows:
Colon cancer treatment is based largely on stage, though biomarker results and overall health also play a role. Patients and their care team work together to decide on a plan, which may include more than one type of treatment. For some patients, colon cancer clinical trials may be an option.
Treatment generally varies between earlier and later stages of colon cancer.
Stage 0 and Stage I colon cancers are often treated with surgery alone. Surgical options may include:
For Stage II colon cancer, surgery may be the only treatment needed. For some patients with Stage II colon cancer, adjuvant chemotherapy may be considered based on MSI/MMR status and other high-risk features, such as:
Stage III colon cancer is typically treated with a partial colectomy followed by adjuvant chemotherapy. This treatment aims to lower the chance of cancer returning and is generally given for three to six months.
For Stage IV colon cancer, surgery may help patients live longer when the cancer has spread to only a few small areas of the liver or lungs. In these cases, the surgeon may remove those areas along with the colon tumor, and chemotherapy may be given before surgery, after surgery, or both.
Other options may include targeted therapy or immunotherapy, depending on the cancer’s biomarkers and other clinical factors. These treatments are matched to specific gene or protein changes in the cancer cells, and immunotherapy may be an option for MSI-high cancers or cancers with MMR gene changes.
A variety of colon cancer specialists may be included in the care team, including:
RCCA’s medical oncologists and hematologists treat cancer and blood disorders with therapies such as chemotherapy, targeted therapy, and immunotherapy. RCCA physicians collaborate and coordinate with other physicians on each patient’s care team. Patients preparing for a visit can learn what to expect at a first oncology appointment.
A second opinion can help confirm a colon cancer diagnosis and treatment plan. The second doctor reviews the pathology report, slides, and scans, and may agree with the first doctor, suggest changes, or provide more information. The time right after diagnosis or a biopsy is often ideal, since patients can explore options before treatment begins.
Records to gather include:
RCCA prioritizes appointments for second opinions to help patients get in quickly and offers telehealth visits when medical records are sufficient. RCCA’s guide to getting a second opinion on a cancer diagnosis explains the process in more detail.
For patients just diagnosed with colon cancer, a colon cancer specialist can explain test results, the staging process, and treatment options. Regional Cancer Care Associates (RCCA) treats cancer and blood disorders, with more than 90 medical oncologists and hematologists caring for more than 30,000 new patients and 265,000 established patients each year. RCCA also offers access to approximately 300 clinical trials at more than 20 locations near you in New Jersey, Connecticut, and Massachusetts. To learn more about RCCA, call 844-346-7222 or contact RCCA online.
What should patients do first after a colon cancer diagnosis?
Common first steps include reviewing the pathology report, completing staging tests, and asking about biomarker testing and a second opinion.
How soon does colon cancer treatment need to start?
Timing depends on each patient’s case. Some people can wait a few weeks to start treatment, which may allow time for test results or a second opinion. The cancer care team can explain when treatment should begin.
How is rectal cancer treatment different from colon cancer treatment?
Both are treated mainly by stage. Treatment for Stage II and Stage III rectal cancer often includes therapy before surgery, which may involve chemotherapy, radiation therapy, or both, depending on the individual treatment plan.
What questions should patients ask at the first colon cancer appointment?
Helpful questions include where the cancer is located, what the stage means, and if more tests are needed before treatment. Patients can also ask if the cancer was checked for gene changes and if a second opinion may help.
When is a colostomy needed after colon cancer surgery?
A colostomy is needed only in some cases. After a partial colectomy, surgeons usually reconnect the remaining sections of colon. When a colostomy, an opening in the abdomen for waste to leave the body, is needed, it may be temporary and reversed later.
What is recovery like after a partial colectomy?
Patients generally advance their diet after surgery as bowel function returns and according to their surgical team’s recommendations. Pain relievers can help with discomfort early on. Patients should follow the post-care instructions provided to them.
Can colon cancer run in families?
Yes. Some colon cancers are linked to Lynch syndrome. When MSI or MMR results point to this condition, the doctor may recommend genetic counseling and testing, and relatives may want to be tested, too.
Are clinical trials an option after a new colon cancer diagnosis?
Clinical trials may be an option for some patients. Since some trials are open only to patients who have not started treatment, it can help to ask the care team about trials before treatment begins.
What colon cancer care does RCCA provide?
RCCA’s colon cancer care may include chemotherapy, targeted therapy, and immunotherapy, along with second opinions and clinical trial access; RCCA also treats blood disorders.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Transportation is an underestimated burden of cancer care. When visiting the oncologist once or twice each week for chemotherapy, the travel time adds up. A

“Unfortunately, your cancer has returned.” It’s news that anyone who has been treated for the disease dreads hearing. And it’s news that far fewer people

Telling a patient that she has or may have cancer can be one of the most challenging tasks a physician faces. And what typically follows
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.